NuCana plc Files Q1 2024 Financial Results
Ticker: NCNA · Form: 6-K · Filed: May 16, 2024 · CIK: 1709626
| Field | Detail |
|---|---|
| Company | Nucana PLC (NCNA) |
| Form Type | 6-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-K, foreign-issuer
TL;DR
NuCana plc dropped its Q1 2024 results on 5/16. Check the 6-K for details.
AI Summary
NuCana plc announced its first quarter 2024 financial results on May 16, 2024. The filing is a Form 6-K, which is a report of a foreign issuer. Specific financial details for the quarter were not fully provided in the excerpt.
Why It Matters
This filing provides an update on NuCana plc's financial performance for the first quarter of 2024, which is important for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This filing is a routine financial results announcement and does not appear to contain significant new risks.
Key Players & Entities
- NuCana plc (company) — Registrant
- May 16, 2024 (date) — Date of press release and filing
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of a foreign issuer, NuCana plc, pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, specifically announcing its first quarter 2024 financial results.
When did NuCana plc announce its first quarter 2024 financial results?
NuCana plc announced its first quarter 2024 financial results on May 16, 2024.
What is NuCana plc's principal executive office address?
NuCana plc's principal executive office is located at 3 Lochside Way, Edinburgh EH12 9DT, United Kingdom.
Does NuCana plc file annual reports on Form 20-F or Form 40-F?
NuCana plc indicates that it files annual reports under cover of Form 20-F.
What is the SIC code for NuCana plc?
The Standard Industrial Classification (SIC) code for NuCana plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-05-16 16:11:50
Filing Documents
- d788163d6k.htm (6-K) — 12KB
- d788163dex991.htm (EX-99.1) — 209KB
- d788163dex992.htm (EX-99.2) — 67KB
- d788163dex993.htm (EX-99.3) — 82KB
- 0001193125-24-140551.txt ( ) — 371KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. NuCana plc By: /s/ Donald Munoz Name: Donald Munoz Title: Chief Financial Officer Date: May 16, 2024